Gastroesophageal Reflux Disease (GERD) Global Market Report 2025
상품코드:1824670
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
위식도 역류질환(GERD) 시장 규모는 향후 수년간 안정된 성장이 예상됩니다. 2029년에는 CAGR 2.8%를 나타내 59억 5,000만 달러로 성장할 전망입니다. 예측 기간 성장은 인구 고령화, 건강 관리 지출 증가, 바이오마커 출현, 소화관 질환 스크리닝 프로그램 증가, 가슴앓이 유병률 증가, 의료기기 수요 증가 등에 기인합니다. 예측 기간의 주요 동향은 진단의 진보, 수술의 진보, 표적요법의 개발, 원격의료서비스의 채용 등입니다.
향후 5년간의 성장률 2.8%라고 하는 예측은 전회 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰로 인해 인도와 이스라엘산 pH 모니터 카테터와 양성자 펌프 억제제의 가격이 25% 상승할 수 있으며, 그 결과 GERD 진단이 지연되고 만성 환자의 소화기내과 약이 30% 상승합니다. 또한 상호 관세와 무역 긴장 증가와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더 광범위하게 늘어날 것으로 보입니다.
알코올 소비의 높은 발생률은 위식도 역류질환(GERD) 시장 성장을 가속할 것으로 예측됩니다. 알코올 소비는 에탄올을 포함한 음료의 섭취를 의미하며, 과다 복용하면 식도 운동을 낮추고 식도 압력 수준을 낮추면 GERD 개발에 기여할 수 있습니다. 예를 들어, 2024년 7월 영국 기관인 하원 도서관은 2022년 영국 성인의 56%가 1주일 동안 알코올을 섭취했다고 보고했습니다. 이 데이터로부터 음주 습관의 남녀 차이가 밝혀졌고, 이 기간에 알코올을 섭취한 적은 남성이 61%, 여성이 51%였습니다. 그 결과, 음주 습관 증가가 위식도 역류질환(GERD) 시장 성장에 박차를 가하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 위식도 역류질환(GERD) : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 위식도 역류질환(GERD) 시장 : 성장률 분석
세계의 위식도 역류질환(GERD) 시장 실적 : 규모와 성장(2019-2024년)
세계의 위식도 역류질환(GERD) 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 위식도 역류질환(GERD) : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 위식도 역류질환(GERD) 시장 : 약제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
프로톤 펌프 억제제
H2 수용체 차단제
프로키네틱 제제
도파민 수용체 길항제
엔도신치
스트레타
에소피엑스
경구적 절개 없는 위저부 성형술(TIF)
세계의 위식도 역류질환(GERD) 시장 : 절차별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
침습적
저침습
세계의 위식도 역류질환(GERD) 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
홈케어
전문 클리닉
세계의 위식도 역류질환(GERD) 시장 : 제산제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
탄산칼슘
수산화마그네슘
수산화알루미늄
세계의 위식도 역류질환(GERD) 시장 : 프로톤 펌프 억제제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
오메프라졸
에소메프라졸
란소프라졸
판토프라졸
라베프라졸
세계의 위식도 역류질환(GERD) 시장 : H2 수용체 차단제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
라니티딘
파모티딘
니자티딘
시메티딘
세계의 위식도 역류질환(GERD) 시장 : 프로키네틱 제제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
메토클로프라미드
돔페리돈
세계의 위식도 역류질환(GERD) 시장 : 도파민 수용체 길항제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
프로클로르페라진
드로페리돌
세계의 위식도 역류질환(GERD) 시장 : 엔도신치 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
내시경 봉합 시스템
세계의 위식도 역류질환(GERD) 시장 : 스트레타 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
고주파 절제 시스템
세계의 위식도 역류질환(GERD) 시장 : 에소피엑스 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구적 위저부 성형술 시스템
세계의 위식도 역류질환(GERD) 시장 : 경구적 절개 없는 위저부 성형술(TIF) 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
TIF 장치 및 시스템
제7장 지역별/국가별 분석
세계의 위식도 역류질환(GERD) 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 위식도 역류질환(GERD) 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
위식도 역류질환(GERD) 시장 : 경쟁 구도
위식도 역류질환(GERD) 시장 : 기업 프로파일
GlaxoSmithKline PLC : 개요, 제품 및 서비스, 전략 및 재무 분석
SRS Life Sciences : 개요, 제품 및 서비스, 전략 및 재무 분석
Johnson & Johnson Services Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Takeda Pharmaceutical Company Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
AstraZeneca Plc : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Reckitt Benckiser Group Plc
Eisai Co. Ltd.
Pfizer Inc.
Medtronic Plc
Teva Pharmaceuticals
HK inno.N Corporation
Sebela Pharmaceuticals
Mylan NV
Bausch Health Companies Inc.
Johnson & Johnson MedTech
Eisai Co. Ltd.
Sun Pharmaceutical Industries Ltd.
Perrigo Company PLC
Dr. Reddy's Laboratories Ltd.
Aurobindo Pharma Limited
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
위식도 역류질환(GERD) 시장(2029년) : 새로운 기회를 제공하는 국가
위식도 역류질환(GERD) 시장(2029년) : 새로운 기회를 제공하는 부문
위식도 역류질환(GERD) 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Gastroesophageal reflux disease (GERD) is a condition characterized by the regurgitation of stomach acid into the esophagus, leading to irritation and discomfort. Treating GERD involves employing a range of medical strategies and interventions to effectively manage its symptoms and associated complications.
The primary drug categories used in the treatment of gastroesophageal reflux disease include antacids, proton pump inhibitors, H2 receptor blockers, prokinetic agents, dopamine receptor antagonists, and minimally invasive procedures such as EndoCinch, Stretta, Asphyx, and Transoral Incisionless Fundoplication (TIF). Antacids, for instance, function by neutralizing stomach acid, thus increasing the stomach's pH level to alleviate symptoms. Additionally, these treatment approaches can be divided into invasive and minimally invasive procedures, offering options that cater to the unique needs of patients. These therapies are made available through various healthcare providers, including hospitals, homecare services, and specialty clinics.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The gastroesophageal reflux disease (GERD) market research report is one of a series of new reports from The Business Research Company that provides gastroesophageal reflux disease (GERD) market statistics, including gastroesophageal reflux disease (GERD) industry global market size, regional shares, competitors with a gastroesophageal reflux disease (GERD) market share, detailed gastroesophageal reflux disease (GERD) market segments, market trends and opportunities and any further data you may need to thrive in the gastroesophageal reflux disease (GERD) industry. This gastroesophageal reflux disease (GERD) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The gastroesophageal reflux disease (gerd) market size has grown marginally in recent years. It will grow from $5.25 billion in 2024 to $5.33 billion in 2025 at a compound annual growth rate (CAGR) of 1.6%. The growth in the historic period can be attributed to lifestyle and dietary changes, obesity epidemic, growing awareness about gerd treatment, globalization of pharmaceutical industry, investments for gerd treatments.
The gastroesophageal reflux disease (gerd) market size is expected to see steady growth in the next few years. It will grow to $5.95 billion in 2029 at a compound annual growth rate (CAGR) of 2.8%. The growth in the forecast period can be attributed to aging population, rising healthcare spending, emergence of biomarker, growing number of screening programs for gerd, increasing prevalence of heartburn, increased demand for medical equipment. Major trends in the forecast period include diagnostic advancements, surgical advancements, development of targeted therapies, adoption of telehealth services.
The forecast of 2.8% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could inflate prices of pH monitoring catheters and proton pump inhibitors from India and Israel by 25%, resulting in delayed GERD diagnoses and 30% higher gastroenterology medication costs for chronic patients. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The high incidence of alcohol consumption is expected to drive the growth of the gastroesophageal reflux disease (GERD) market. Alcohol consumption refers to the ingestion of beverages containing ethanol, which, when consumed in excess, can contribute to the development of GERD by reducing esophageal motility and lowering the pressure levels in the esophagus. For example, in July 2024, the House of Commons Library, a UK-based institution, reported that in 2022, 56% of adults in England had consumed alcohol in the past week. This data revealed a gender difference in drinking habits, with 61% of men and 51% of women having consumed alcohol during this period. Consequently, the increasing prevalence of alcohol consumption is fueling the growth of the GERD market.
Prominent companies operating in the gastroesophageal reflux disease (GERD) market are dedicated to the introduction of innovative treatment devices for GERD, aimed at maintaining their market leadership. For example, in April 2023, Laborie Medical Technologies, a US-based medical technology firm, unveiled the alpHaONE wireless pH-capsule reflux testing diagnostic system, designed specifically for the diagnosis of gastroesophageal reflux disease (GERD). This advanced system is capable of providing up to 96 hours of comprehensive monitoring data. Notably, it boasts a compact and user-friendly design with conveniently enlarged buttons and a dependable capsule delivery system. Moreover, it features a dedicated software application equipped with a virtual instruction program and the option for users to customize symptom buttons, thereby enhancing the overall user experience. This innovative approach is significantly impacting the evolution of the GERD treatment market.
In October 2022, Sebela Pharmaceuticals Inc., a US-based pharmaceutical company specializing in the production of gastroesophageal reflux disease medications, established a strategic partnership with HK Inno.N Corporation, a South Korea-based pharmaceutical company, in an arrangement involving an undisclosed sum. This collaboration is aimed at jointly developing and launching tegoprazan, a pioneering potassium-competitive acid blocker (P-CAB), within the US and Canada. Tegoprazan, already authorized and available in South Korea and China, holds significant promise as an innovative addition to Sebela Pharmaceuticals' gastroenterology product line, catering to individuals dealing with gastroesophageal reflux disease.
Major companies operating in the gastroesophageal reflux disease (GERD) market are GlaxoSmithKline PLC, SRS Life Sciences, Johnson & Johnson Services Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Reckitt Benckiser Group PLC, Eisai Co. Ltd., Pfizer Inc., Medtronic PLC, Teva Pharmaceuticals, HK inno.N Corporation, Sebela Pharmaceuticals, Mylan N.V., Bausch Health Companies Inc., Johnson & Johnson MedTech, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Salix Pharmaceuticals Inc., Almirall S.A., HK inno.N Corporation, SRS Life Sciences Pte. Ltd.
North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gastroesophageal reflux disease (GERD) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the gastroesophageal reflux disease (GERD) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The gastroesophageal reflux disease (GERD) market consists of revenues earned by entities by providing pharmaceutical therapies, surgical procedures and diagnostic tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastroesophageal reflux disease (GERD) market also includes sales of gamma-aminobutyric acid type B receptor agonists and alginate antacids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Gastroesophageal Reflux Disease (GERD) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on gastroesophageal reflux disease (gerd) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for gastroesophageal reflux disease (gerd) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastroesophageal reflux disease (gerd) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drug Type: Antacids; Proton Pump Inhibitors; H2 Receptor Blocker; Pro Kinetic Agents; Dopamine Receptor Antagonist; EndoCinch; Stretta; EsophyX; Transoral Incisionless Fundoplication (TIF)
2) By Procedure: Invasive; Minimally Invasive
3) By End-Users: Hospital; Homecare; Specialty Clinics
Subsegments:
1) By Antacids: Calcium Carbonate; Magnesium Hydroxide; Aluminum Hydroxide
2) By Proton Pump Inhibitors: Omeprazole; Esomeprazole; Lansoprazole; Pantoprazole; Rabeprazole
3) By H2 Receptor Blockers: Ranitidine; Famotidine; Nizatidine; Cimetidine
4) By Prokinetic Agents: Metoclopramide; Domperidone
5) By Dopamine Receptor Antagonists: Prochlorperazine; Droperidol
6) By EndoCinch: Endoscopic Suturing Systems
7) By Stretta: Radiofrequency Ablation Systems
8) By EsophyX: Transoral Fundoplication Systems
9) By Transoral Incisionless Fundoplication (TIF): TIF Devices And Systems
Companies Mentioned: GlaxoSmithKline PLC; SRS Life Sciences; Johnson & Johnson Services Inc.; Takeda Pharmaceutical Company Limited; AstraZeneca Plc; Reckitt Benckiser Group Plc; Eisai Co. Ltd.; Pfizer Inc.; Medtronic Plc; Teva Pharmaceuticals; HK inno.N Corporation; Sebela Pharmaceuticals; Mylan N.V.; Bausch Health Companies Inc.; Johnson & Johnson MedTech; Eisai Co. Ltd.; Sun Pharmaceutical Industries Ltd.; Perrigo Company PLC; Dr. Reddy's Laboratories Ltd.; Aurobindo Pharma Limited; Cipla Limited; Ferring B.V.; Amneal Pharmaceuticals LLC; Zydus Lifesciences Ltd.; Lupin Limited; Torrent Pharmaceuticals Ltd.; Salix Pharmaceuticals Inc.; Almirall S.A.; HK inno.N Corporation; SRS Life Sciences Pte. Ltd.
3. Gastroesophageal Reflux Disease (GERD) Market Trends And Strategies
4. Gastroesophageal Reflux Disease (GERD) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Gastroesophageal Reflux Disease (GERD) Growth Analysis And Strategic Analysis Framework
5.1. Global Gastroesophageal Reflux Disease (GERD) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Gastroesophageal Reflux Disease (GERD) Market Growth Rate Analysis
5.4. Global Gastroesophageal Reflux Disease (GERD) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Gastroesophageal Reflux Disease (GERD) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Gastroesophageal Reflux Disease (GERD) Total Addressable Market (TAM)
6.1. Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Proton Pump Inhibitors
H2 Receptor Blocker
Pro Kinetic Agents
Dopamine Receptor Antagonist
EndoCinch
Stretta
EsophyX
Transoral Incisionless Fundoplication (TIF)
6.2. Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Invasive
Minimally Invasive
6.3. Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Homecare
Specialty Clinics
6.4. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Calcium Carbonate
Magnesium Hydroxide
Aluminum Hydroxide
6.5. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Proton Pump Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Omeprazole
Esomeprazole
Lansoprazole
Pantoprazole
Rabeprazole
6.6. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of H2 Receptor Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ranitidine
Famotidine
Nizatidine
Cimetidine
6.7. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Prokinetic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Metoclopramide
Domperidone
6.8. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Dopamine Receptor Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prochlorperazine
Droperidol
6.9. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of EndoCinch, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Endoscopic Suturing Systems
6.10. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Stretta, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Radiofrequency Ablation Systems
6.11. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of EsophyX, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Transoral Fundoplication Systems
6.12. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Transoral Incisionless Fundoplication (TIF), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
TIF Devices And Systems
7. Gastroesophageal Reflux Disease (GERD) Market Regional And Country Analysis
7.1. Global Gastroesophageal Reflux Disease (GERD) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Gastroesophageal Reflux Disease (GERD) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Gastroesophageal Reflux Disease (GERD) Market
9.1. China Gastroesophageal Reflux Disease (GERD) Market Overview
9.2. China Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Gastroesophageal Reflux Disease (GERD) Market
10.1. India Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Gastroesophageal Reflux Disease (GERD) Market
11.1. Japan Gastroesophageal Reflux Disease (GERD) Market Overview
11.2. Japan Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Gastroesophageal Reflux Disease (GERD) Market
12.1. Australia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Gastroesophageal Reflux Disease (GERD) Market
13.1. Indonesia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Gastroesophageal Reflux Disease (GERD) Market
14.1. South Korea Gastroesophageal Reflux Disease (GERD) Market Overview
14.2. South Korea Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Gastroesophageal Reflux Disease (GERD) Market
15.1. Western Europe Gastroesophageal Reflux Disease (GERD) Market Overview
15.2. Western Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Gastroesophageal Reflux Disease (GERD) Market
16.1. UK Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Gastroesophageal Reflux Disease (GERD) Market
21.1. Eastern Europe Gastroesophageal Reflux Disease (GERD) Market Overview
21.2. Eastern Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Gastroesophageal Reflux Disease (GERD) Market
22.1. Russia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Gastroesophageal Reflux Disease (GERD) Market
23.1. North America Gastroesophageal Reflux Disease (GERD) Market Overview
23.2. North America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Gastroesophageal Reflux Disease (GERD) Market
24.1. USA Gastroesophageal Reflux Disease (GERD) Market Overview
24.2. USA Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Gastroesophageal Reflux Disease (GERD) Market
26.1. South America Gastroesophageal Reflux Disease (GERD) Market Overview
26.2. South America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Gastroesophageal Reflux Disease (GERD) Market
27.1. Brazil Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Gastroesophageal Reflux Disease (GERD) Market
28.1. Middle East Gastroesophageal Reflux Disease (GERD) Market Overview
28.2. Middle East Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Gastroesophageal Reflux Disease (GERD) Market
29.1. Africa Gastroesophageal Reflux Disease (GERD) Market Overview
29.2. Africa Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Gastroesophageal Reflux Disease (GERD) Market Competitive Landscape And Company Profiles
